Curetis Eyes IPO on Euronext

Oct 14, 2015

|

NEW YORK (GenomeWeb) – Curetis today announced its intent to issue an initial public offering of new ordinary shares in Europe.

The firm, which is based in Germany, also announced a newly incorporated holding company in the Netherlands.

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.